Immutep Announces Strong Operational Progress in Global TACTI-004 (KEYNOTE-F91) Phase III and Enrolment Continues at Robust Pace

The registrational TACTI-004 Phase III has enrolled 289 patients globally, over 38% of the trial’s targeted enrolmentStrong ...

5 things to know before the stock market opens

Stock futures are slightly lower this morning ahead of the release of highly anticipated labor market data; the government is scheduled to release two months of employment figures that were delayed ...